Completed
Efficacy of QAX576 in Asthma
NCT01130064
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Novartis Investigative Site Phoenix, Arizona, United States
- Novartis Investigative Site Huntington Beach, California, United States
- Novartis Investigative Site Owensboro, Kentucky, United States
- Novartis Investigative Site Wheaton, Maryland, United States